NCT05381519 A Study to Evaluate the Efficacy and Safety of DXP604 in Patients With Mild to Moderate COVID-19 Status UNKNOWN Phase PHASE2
NCT05381454 An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness Status COMPLETED Phase PHASE1/PHASE2
NCT05381363 Inhaled Interferon α2b Treatment in Mild-to-moderate COVID-19 Infected Children Status TERMINATED Phase PHASE1/PHASE2
NCT05381350 Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above Status COMPLETED Phase PHASE3
NCT05379621 Socio-economic, Meteorological and Environmental Factors Associated With the Incidence of COVID-19 Status COMPLETED Phase N/A
NCT05379608 Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection. Status COMPLETED Phase NA
NCT05379543 Echocardiographic Manifestation in Patients With Omicron Variant of COVID-19 Status UNKNOWN Phase N/A
NCT05379517 Pulmonary Rehabilitation Program With Pulsed Electromagnetic Field Therapy in Patients With Post-covid Sequelae. Status UNKNOWN Phase NA
NCT05375799 Clinical and Electronic Record for Patients With COVID-19 Treated With the Assisted Breathing Helmet - ELMO in Ceará Status UNKNOWN Phase N/A
NCT05375786 Epidemiological Study on Asymptomatic Infections and Mild Illness With Covid-19 in Shanghai Status UNKNOWN Phase N/A
NCT05375058 Complicated Appendicitis During the COVID-19 Pandemic in Jordan Status COMPLETED Phase N/A
NCT05374954 Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and Above Status UNKNOWN Phase PHASE3
NCT05374772 A Retrospective Study in Patients With Mild to Moderate COVID-19 Status UNKNOWN Phase N/A
NCT05374577 Pulmonary Vascular Dysfunction as a Cause of Persistent Exertional Dyspnea After Coronavirus Disease (COVID-19) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05373485 Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older Status COMPLETED Phase PHASE1
NCT05373472 Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older Status COMPLETED Phase PHASE2
NCT05373446 Evaluation of SSD8432 and Ritonavir in Adult Subjects With COVID-19 Clinical Study Status UNKNOWN Phase PHASE2